Key result
Administration of of paroxetine reduced exercise time to exhaustion compared to placebo, supporting a central serotoninergic component to fatigue.
Why the study?
Does paroxetine reduce exercise time to exhaustion in healthy subjects?
RCT (n=7)
Does paroxetine reduce exercise time to exhaustion in healthy subjects?
Administration of the serotonin re-uptake inhibitor paroxetine reduces the capacity to perform prolonged exercise, suggesting a central component to fatigue mediated by serotoninergic neurons.
Answers are grounded in this paper and cite their sources.
Paroxetine may impair prolonged exercise capacity in healthy subjects; extends evidence for serotonergic mediation of central fatigue.
Seven healthy subjects exercised to exhaustion on a bicycle ergometer at a power output corresponding to 70% of maximum oxygen uptake after administration of either a placebo or 20 mg of paroxetine, a serotonin re-uptake inhibitor. Exercise time after paroxetine (median 94 min; range 84-127 min) was less (P < 0.05) than after placebo (median 116 min; range 86-133 min). The metabolic and cardiorespiratory responses to exercise were the same in both trials. This result supports the suggestion that there is a central component to fatigue which is mediated by the activity of serotoninergic neurones.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (1992) conducted an RCT in Healthy subjects (n=7). Paroxetine vs. Placebo was evaluated on Exercise time to exhaustion on a bicycle ergometer at 70% of maximum oxygen uptake (p=< 0.05). Administration of of paroxetine reduced exercise time to exhaustion compared to placebo, supporting a central serotoninergic component to fatigue.
Synapse has enriched 10 related papers. Consider them for comparative context: